1
A Study of Icatibant for Acute Attacks of Hereditary Angioedema in Japanese Participants
Condition(s):Hereditary Angioedema (HAE)Last Updated:September 3, 2019Completed
Icatibant as an Intervention: 21 Clinical Trials
Hide Studies Not Open or Pending
2
A Pharmacokinetic, Tolerability and Safety Study of Icatibant in Children and Adolescents With Hereditary Angioedema
Condition(s):Hereditary Angioedema (HAE)Last Updated:March 21, 2019Completed
3
FIRAZYR General Drug Use-Results Survey (Japan)
Condition(s):Hereditary Angioedema (HAE)Last Updated:August 13, 2019Recruiting
4
Open-label, Single-arm Study to Assess the Pharmacokinetics, Safety, and Tolerability of a Single Subcutaneous Dose of Icatibant in Healthy Japanese Volunteers
Condition(s):Hereditary Angioedema (HAE)Last Updated:January 6, 2015Completed
5
Blinded Safety & Efficacy Placebo Controlled Study of Icatibant for Angiotensin Converting Enzyme Inhibitor Induced Angioedema
Condition(s):Angiotensin Converting Enzyme Inhibitor Induced AngioedemaLast Updated:November 26, 2018Completed
6
Efficacy, Safety and Tolerability of Icatibant for the Treatment of HAE
Condition(s):Hereditary AngioedemaLast Updated:October 17, 2016Completed
7
EASSI – Evaluation of the Safety of Self-Administration With Icatibant
Condition(s):Hereditary AngioedemaLast Updated:June 30, 2014Completed
8
A Study of Icatibant in Patients With Acute Attacks of Hereditary Angioedema (FAST-3)
Condition(s):Hereditary AngioedemaLast Updated:September 11, 2014Completed
9
Subcutaneous Treatment With Icatibant for Acute Attacks of Hereditary Angioedema
Condition(s):AngioedemaLast Updated:May 22, 2014Completed
10
Mitochondria and Chronic Kidney Disease
Condition(s):Hemodialysis-Induced Symptom; Mitochondrial DiseasesLast Updated:April 3, 2019Completed
11
Subcutaneous Treatment With Icatibant for Acute Attacks of Hereditary Angioedema (HAE)
Condition(s):Hereditary AngioedemaLast Updated:January 29, 2015Completed
12
Efficacy and Safety Study of Intra-articular Multiple Doses of Icatibant in Patients With Painful Knee Osteoarthritis
Condition(s):Joint DiseaseLast Updated:February 15, 2012Completed
13
Effect of Bradykinin Receptor Antagonism on ACE Inhibitor-associated Angioedema
Condition(s):ACE Inhibitor-associated AngioedemaLast Updated:December 22, 2016Terminated
14
Bradykinin Receptor Blocker in ACE Inhibitor-associated Angioedema
Condition(s):Angioneurotic EdemaLast Updated:December 16, 2015Terminated
15
Firazyr® Patient Registry (Icatibant Outcome Survey – IOS)
Condition(s):Hereditary Angioedema (HAE)Last Updated:May 31, 2019Recruiting
16
AMelioration of Angiotensin Converting Enzyme Inhibitor Induced Angioedema Study
Condition(s):AngioedemaLast Updated:December 22, 2011Completed
17
Bradykinin Receptor Antagonism During Cardiopulmonary Bypass
Condition(s):Cardiopulmonary Bypass; Inflammation; Fibrinolysis; SurgeryLast Updated:October 15, 2013Completed
18
Mechanisms Underlying Hypotensive Response to ARB/NEP Inhibition – Aim 2
Condition(s):Heart FailureLast Updated:September 30, 2019Not yet recruiting
19
The Effect of Ischaemic-Reperfusion in Man – A Bradykinin Dependent Pathway
Condition(s):Ischaemic Heart DiseasesLast Updated:October 22, 2010Completed
20
The Effect of Ischaemic-Reperfusion and Remote Ischaemic Preconditioning in Man – A Bradykinin Dependent Pathway
Condition(s):Ischaemic Heart DiseasesLast Updated:October 22, 2010Completed
21
Mechanism(s) Underlying Cardiovascular Effects of ARB/NEP Inhibition – Aim 2
Condition(s):Heart Failure NYHA Class I; Heart Failure NYHA Class II; Heart Failure NYHA Class IIILast Updated:January 9, 2018Withdrawn